Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News by ticker →AAPL news SPY news Earnings

News Feed

2 results loaded, newest first. End of these results.

News 2026-09-21 06:23 UTC

AstraZeneca says EU regulator recommends Enhertu approval for early breast cancer

AstraZeneca Plc said the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended Enhertu for approval as adjuvant treatment for HER2-positive early breast cancer.

AZN.L

News 2026-09-21 06:22 UTC

AstraZeneca says Enhertu recommended for EU approval in early breast cancer

AstraZeneca said its breast cancer therapy Enhertu has been recommended for approval by EU regulators for early breast cancer.

AZN

Search market news

Matching instruments

AstraZeneca says EU regulator recommends Enhertu approval for early breast cancer

AstraZeneca says Enhertu recommended for EU approval in early breast cancer